6Deckelbaum LI,Sax FL, Grossman W. Tirofiban, a nonpeptide inhibit or of the platelet glycoprotein Ⅱ b/Ⅲa receptors//Sasahara AA, Loscalzo J. New therapeutic agents in thrombosis and thrombolysis. New York:Marcel Dekker, 1997:355-365.
8Abbas A E, Boura J A,Acute angiographic analysis of non- ST- segment elevation acute myocardial infarction[J]. J Am Cardiol, 2004,94(7):907 - 909.
9Cohen M, Theroux P. Randomized double - blind safety study of enoxaparin versus unfractionated heparin in patients with non- STsegment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE Ⅱ study( the antithrombotic combination using tirofiban and enoxaparin) [J]. Am Heart J, 2002, 144 (3):470 - 477.
10Kandzari D E. Current concepts in the antithrombotic management of non- ST- elevation acute coronary syndromes[J]. Curr Cardiol Rep,2004,6 (4): 279 - 286.
